Skip to main content

CTOS 2024 Main banner

Schedule at a Glance

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Mei-Yu Fang, MD

Department of Head and Neck and Rare Tumors Internal Medicine, ZheJiang Cancer Hospital, Hangzhou, China, China (People's Republic)

Poster(s):

(P 416) TRIPLR COMNINATION THERAPY IN THE FIRST-LINE TREATMENT OF SOFT TISSUE SARCOMA WITH HIGH TUMOR BURDEN: INTERIM ANALYSIS FROM ALTER-S007 STUDY